-
FAERS DATABASE ANALYSIS REVEALS ANENCEPHALY ASSOCIATED WITH ANTIRETROVIRAL DRUG EXPOSURE
Mar 18, 2026, 21:38 PM -
EXPLORING PREFERENCES FOR LYME DISEASE VACCINES IN THE UNITED STATES: A LATENT CLASS APPROACH
Mar 18, 2026, 21:38 PM -
BREAST CANCER PATTERNS AND TREATMENT ACCESS IN DENMARK: IDENTIFYING OPPORTUNITIES FOR DECENTRALIZED CARE IN BREAST CANCER CARE (HEATMAP-ONKO-BREAST)
Mar 18, 2026, 21:38 PM -
FROM TEXT TO SIGNAL: EVALUATING LLMS FOR VALID CASE IDENTIFICATION IN PHARMACOVIGILANCE
Mar 18, 2026, 21:38 PM -
SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD DIAGNOSTIC DELAY, TREATMENT ACCESS, AND HEALTH SYSTEM BURDEN IN PRIMARY IMMUNODEFICIENCY/INBORN ERRORS OF IMMUNITY: EVIDENCE FROM THE UNITED STATES AND EX-US SETTINGS
Mar 18, 2026, 21:38 PM -
COST-UTILITY ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE VERSUS FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL FOR MODERATE-TO-VERY SEVERE COPD IN CHINA
Mar 18, 2026, 21:38 PM -
WHY CURRENT INTERTEMPORAL DISCOUNTING METHODS ARE WRONG, HOW THEY DISTORT HEALTH TECHNOLOGY ASSESSMENT, COST-EFFECTIVENESS ANALYSIS AND ESTIMATES OF THE VALUE OF A LIFE-YEAR AT FULL HEALTH, AND HOW TO FIX THE PROBLEM
Mar 18, 2026, 21:38 PM -
REAL-WORLD PERIOPERATIVE IMMUNOTHERAPY AND CELLULAR THERAPY IN OLDER ADULTS WITH SOLID TUMORS: A 2021-2025 MEDICARE-EMR LINKED ANALYSIS
Mar 18, 2026, 21:38 PM -
WHEN IS REAL-WORLD EVIDENCE SCIENTIFICALLY SOUND? EXPERT CONSENSUS ON SASS FOR CFL COMMUNICATION
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A COST UTILITY MODEL TO ASSESS THE INCREMENTAL COST EFFECTIVENESS OF CONTINUOUS DUAL GLUCOSE KETONE MONITORING SYSTEM VERSUS CONTINUOUS GLUCOSE MONITORING SYSTEM IN PEOPLE WITH DIABETES
Mar 18, 2026, 21:38 PM -
COMPARISON OF BENEFIT DESIGN FOR DIABETES MEDICATIONS BETWEEN CONVENTIONAL MEDICARE ADVANTAGE PLANS AND CHRONIC CONDITION SPECIAL NEEDS PLANS
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN AND COST EFFECTIVENESS OF ADVANCED GALLBLADDER CANCER TREATMENT IN NORTHEAST INDIA: A DUAL PHASE ASSESSMENT
Mar 18, 2026, 21:38 PM -
BURNOUT AMONG EMERGENCY CARE STAFF IN HUNGARY: PREVALENCE AND INTERVENTION POSSIBILITIES - A QUASI-EXPERIMENTAL STUDY
Mar 18, 2026, 21:38 PM -
CHARACTERIZING AUTOIMMUNE FLARES IN REAL WORLD SETTINGS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS ENROLLED IN AN ONLINE COMMUNITY
Mar 18, 2026, 21:38 PM -
THE BLOCKBUSTER BATTLE IN OBESITY: DO NEWER SEMAGLUTIDE DOSES CLOSE THE GAP? A TIME-COURSE MODEL-BASED NMA
Mar 18, 2026, 21:38 PM -
PREDICTING OPIOID COST BURDEN THROUGH INTEGRATED PBM AND SDOH MODELING: AN EXPLAINABLE AI FRAMEWORK FOR U.S. COUNTY-LEVEL FORECASTING
Mar 18, 2026, 21:38 PM -
ANALYSIS OF HOSPITAL LENGTH OF STAY IN HONG KONG: EFFECTS OF AGE, CONDITIONS, AND COMORBIDITY INTERACTIONS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF THE TRADITIONS AND CONNECTIONS FOR URBAN NATIVE AMERICANS (TACUNA) INTERVENTION
Mar 18, 2026, 21:38 PM
